Recombinant Human SUZ12 Protein，His

SUZ12 is a crucial component of the Polycomb Repressive Complex 2 (PRC2), which plays a vital role in epigenetic regulation by mediating gene silencing through histone methylation. Research on SUZ12 has gained prominence due to its involvement in developmental processes and its implications in various cancers. Abnormal expression or mutations of SUZ12 can disrupt normal gene regulatory mechanisms, leading to uncontrolled cell proliferation and tumorigenesis. Studies have demonstrated that SUZ12 interacts with other key proteins within the PRC2 complex, such as EZH2, a histone methyltransferase, and EED, which are essential for the complex's function. Understanding the structural and functional dynamics of SUZ12 and its interactions can provide insights into the molecular pathways that govern stem cell maintenance, differentiation, and the epigenetic landscapes of cancer. Additionally, SUZ12 has been identified as a potential therapeutic target, as inhibiting its function might restore normal gene expression patterns in malignancies. The ongoing research efforts are directed toward elucidating the regulatory mechanisms involving SUZ12, its contribution to epigenetic memory, and the development of small-molecule inhibitors that could modulate its activity for therapeutic benefits. Overall, the study of SUZ12 and its role within PRC2 is crucial for advancing our understanding of both fundamental biological processes and the development of novel cancer therapies.